Alternatively, continued regulatory restriction could push more research into countries with more permissive frameworks, potentially fragmenting the evidence base geographically
Most commercial payers don't require NDC on professional CMS-1500 claims
Barrett called it a response to concerns raised during the Senate process and said additional amendments could still be filed before a vote
In 2025, the scientific community continues to push the boundaries of knowledge surrounding these remarkable molecules
61 : 54325440 Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, Shi GY, Jia PM, Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang ZY, de The H, Chen SJ and Chen Z (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I